MYELOPROLIFERATIVE SYNDROME
Clinical trials for MYELOPROLIFERATIVE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE SYNDROME trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Donor immune cells get a boost in new cancer trial
Disease control TerminatedThis early-phase study tests whether giving healthy donor NK cells along with two medicines (vactosertib and IL-2) is safe and helps the cells stay active in people with advanced colorectal, stomach, esophageal, or blood cancers. The NK cells are meant to attack cancer, but the b…
Matched conditions: MYELOPROLIFERATIVE SYNDROME
Phase: PHASE1 • Sponsor: David Wald • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New transplant recipe may tame Graft-Versus-Host disease in blood cancer patients
Disease control OngoingThis study tests a specific timing of chemotherapy drugs (busulfan and fludarabine) before a donor stem cell transplant, followed by cyclophosphamide after the transplant, to treat high-risk blood cancers like leukemia and lymphoma. The goal is to reduce the chance of the transpl…
Matched conditions: MYELOPROLIFERATIVE SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC